SCHEMBL11169289

SCHEMBL11169289

COc1cc2c(c(Sc3ccccc3)c1OC)CCN(C)CC2OC(=O)/C=C/C(=O)OC1CN(C)CCc2c1cc(OC)c(OC)c2Sc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ MAPT P10636 2/20 0.35
▸ GAA P10253 1/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HTT P42858 1/20 0.35
▸ TAAR1 Q96RJ0 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ DRD1 P21728 1/20 0.34
▸ DRD5 P21918 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ HTR1A P08908 1/20 0.33
▸ ABCB1 P08183 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ NPY1R P25929 1/20 0.33
▸ NPY2R P49146 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11169440 0.87 KDM4E (0.32) CYP3A4CYP2D6DRD1DRD5KDM4E
SCHEMBL10700513 0.82 CYP3A4 (0.47) CYP3A4CYP2D6ALDH1A1HTTDRD1
Fumaric Acid SCHEMBL11169294 0.77 MEN1 (0.43) CYP3A4CYP2D6MAPTGAAALDH1A1
Fumaric Acid SCHEMBL11169280 0.77 MEN1 (0.43) CYP3A4CYP2D6MAPTGAAALDH1A1
SCHEMBL10702749 0.75 DRD1 (0.41) CYP3A4CYP2D6MAPTMEN1KMT2A
SCHEMBL11160967 0.74 DRD1 (0.47) CYP3A4CYP2D6DRD1DRD5POLB
SCHEMBL11171000 0.70 DRD1 (0.38) CYP3A4CYP2D6MAPTGAAALDH1A1
SCHEMBL11160646 0.68 GAA (0.47) MAPTGAAALDH1A1HTTMEN1
SCHEMBL11160737 0.67 DRD1 (0.43) MAPTDRD1DRD5KDM4ESMN1; SMN2
SCHEMBL11168165 0.66 SMN1; SMN2 (0.36) DRD1DRD5HTR1ANPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0080012-A1 6-Chloro-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, its acid addition salts and its use as an intermediate SMITHKLINE BECKMAN CORPORATION (US) 1983-06-01 — — EP disclosed
EP-0007070-B1 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS HAVING DOPAMINE RECEPTOR BLOCKING ACTIVITY SMITHKLINE BECKMAN CORPORATION (US) 1983-01-19 — — EP disclosed
US-4265890-A ANTIPSYCHOTIC, ANTIEMETICS SMITHKLINE CORPORATION (US) 1981-05-05 — — US disclosed
EP-0007070-A1 2,3,4,5-Tetrahydro-1H-3-Benzazepines, process for their production and pharmaceutical compositions having dopamine receptor blocking activity SMITHKLINE BECKMAN CORPORATION (US) 1980-01-23 — — EP disclosed
Send feedback